{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:24:56Z","timestamp":1761675896615,"version":"3.38.0"},"publisher-location":"Berlin, Heidelberg","reference-count":32,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642701429"},{"type":"electronic","value":"9783642701405"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1985]]},"DOI":"10.1007\/978-3-642-70140-5_22","type":"book-chapter","created":{"date-parts":[[2011,10,25]],"date-time":"2011-10-25T18:06:39Z","timestamp":1319565999000},"page":"182-190","source":"Crossref","is-referenced-by-count":10,"title":["Pharmacological Differentiation of Dopamine D-1 and D-2 Antagonists After Single and Repeated Administration"],"prefix":"10.1007","author":[{"given":"A. V.","family":"Christensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Arnt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"22_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1600-0773.1982.tb01032.x","volume":"51","author":"J Arnt","year":"1982","unstructured":"Arnt J (1982) Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade. Acta Pharmacol Toxicol 51: 321\u2013329","journal-title":"Acta Pharmacol Toxicol"},{"key":"22_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0014-2999(81)90608-7","volume":"69","author":"J Arnt","year":"1981","unstructured":"Arnt J, Christensen AV (1981) Differential reversal by scopolamine and THIP of the antistereotypic and cataleptic effects of neuroleptics. Eur J Pharmacol 69: 107\u2013111","journal-title":"Eur J Pharmacol"},{"key":"22_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/0014-2999(84)90267-X","volume":"102","author":"J Arnt","year":"1984","unstructured":"Arnt J, Hyttel J (1984) Differential inhibition by dopamine D-1 and D-2 antagonists of circling behavior induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions. Eur J Pharmacol 102: 349\u2013354","journal-title":"Eur J Pharmacol"},{"key":"22_CR4","first-page":"1331","volume":"20","author":"J Arnt","year":"1981","unstructured":"Arnt J, Christensen AV, Hyttel J (1981) Differential reversal by scopolamine of effects of neuroleptics in rats. Relevance for evaluation of therapeutic and extrapyramidal side-effect potential. Neuropharmacology 20: 1331\u20131334","journal-title":"Neuropharmacology"},{"key":"22_CR5","first-page":"329","volume":"3","author":"AY Christensen","year":"1982","unstructured":"Christensen AY, Hyttel J (1982) Neuroleptics and the clinical implications of adaptation of dopamine neurons. Pharm Int 3: 329\u2013332","journal-title":"Pharm Int"},{"key":"22_CR6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-94-011-6381-1_4","volume-title":"Tardive dyskinesia, research and treatment","author":"AV Christensen","year":"1980","unstructured":"Christensen AV, M\u00f8ller Nielsen I (1980) On the supersensitivity of DA receptors after single and repeated administration of neuroleptics. In: Smith RC (ed) Tardive dyskinesia, research and treatment. Spectrum, New York, pp 35\u201350"},{"key":"22_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00423298","volume":"48","author":"AV Christensen","year":"1976","unstructured":"Christensen AV, Fjalland B, M\u00f8ller Nielsen I (1976) On the supersensitivity of dopamine receptors, induced by neuroleptics. Psychopharmacology 48: 1\u20136","journal-title":"Psychopharmacology"},{"key":"22_CR8","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/0024-3205(79)90010-9","volume":"24","author":"AV Christensen","year":"1979","unstructured":"Christensen AV, Arnt J, Scheel-Kr\u00fcger J (1979) Decreased antistereotypic effect of neuroleptics after additional treatment with a benzodiazepine, a GABA agonist or an anticholinergic compound. Life Sci 24: 1395\u20131402","journal-title":"Life Sci"},{"issue":"2","key":"22_CR9","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/0361-9230(80)90149-5","volume":"5","author":"AV Christensen","year":"1980","unstructured":"Christensen AV, Arnt J, Scheel-Kr\u00fcger J (1980) GABA-dopamine\/neuroleptic interaction after systemic administration. Brain Res Bull 5 [Suppl 2]: 885\u2013890","journal-title":"Brain Res Bull"},{"key":"22_CR10","first-page":"316","volume-title":"Catecholamines","author":"AV Christensen","year":"1984","unstructured":"Christensen AV, Arnt J, Svendsen O (1984a) Animal models for neuroleptic induced neurological dysfunction. In: Usdin E (ed) Catecholamines 3. Liss, New York, pp 316\u2013328"},{"key":"22_CR11","first-page":"245","volume":"36","author":"AV Christensen","year":"1984","unstructured":"Christensen AV, Arnt J, Hyttel J, Svendsen O (1984b) Behavioral correlates to the dopamine D-1 and D-2 antagonists. Pol J Pharmacol Pharm 36: 245\u2013260","journal-title":"Pol J Pharmacol Pharm"},{"key":"22_CR12","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/0024-3205(84)90607-6","volume":"34","author":"AV Christensen","year":"1984","unstructured":"Christensen AV, Arnt J, Hyttel J, Larsen J-J, Svendsen O (1984c) Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics. Life Sci 34: 1529\u20131540","journal-title":"Life Sci"},{"key":"22_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0014-2999(79)90499-0","volume":"57","author":"A Clow","year":"1979","unstructured":"Clow A, Jenner P, Marsden CD (1979a) Changes in dopamine-mediated behavior during one year\u2019s neuroleptic administration. Eur J Pharmacol 57: 365\u2013375","journal-title":"Eur J Pharmacol"},{"key":"22_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/278059a0","volume":"278","author":"A Clow","year":"1979","unstructured":"Clow A, Jenner P, Theodorou A, Marsden CD (1979b) Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six months. Nature 278: 59\u201361","journal-title":"Nature"},{"key":"22_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/BF00423315","volume":"48","author":"R Dunstan","year":"1976","unstructured":"Dunstan R, Jackson DM (1976) The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol. Psychopharmacology 48: 105\u2013114","journal-title":"Psychopharmacology"},{"key":"22_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1440-1681.1977.tb02613.x","volume":"4","author":"R Dunstan","year":"1977","unstructured":"Dunstan R, Jackson DM (1977) The effect of apomorphine and clonidine on locomotor activity in mice after long-term treatment with haloperidol. Clin Exp Pharmacol Physiol 4: 131\u2013141","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"22_CR17","first-page":"209","volume":"26","author":"J Gerlach","year":"1979","unstructured":"Gerlach J (1979) Tardive dyskinesia. Dan Med Bull 26: 209\u2013245","journal-title":"Dan Med Bull"},{"key":"22_CR18","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/0024-3205(78)90033-4","volume":"23","author":"J Hyttel","year":"1978","unstructured":"Hyttel J (1978) Effects of neuroleptics on 3H-haloperidol and 3H\u2013cis(Z)-flupenthixol binding and on adenylate cyclase activity in vitro. Life Sci 23: 551\u2013556","journal-title":"Life Sci"},{"key":"22_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0014-2999(83)90381-3","volume":"91","author":"J Hyttel","year":"1983","unstructured":"Hyttel J (1983) SCH 23390 - The first selective dopamine D-1 antagonist. Eur J Pharmacol 91: 153\u2013154","journal-title":"Eur J Pharmacol"},{"key":"22_CR20","first-page":"136","volume":"23","author":"LC Iorio","year":"1981","unstructured":"Iorio LC, Houser V, Korbuda CA, Leitz F, Barnett A (1981) SCH 23390, a benzazepine with atypical effects on dopaminergic systems. Pharmacologist 23: 136","journal-title":"Pharmacologist"},{"key":"22_CR21","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0022-3565(25)21599-3","volume":"226","author":"LC Iorio","year":"1983","unstructured":"Iorio LC, Barnett A, Leitz FH, Houser VP, Korbuda CA (1983) SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J Pharm Exp Ther 226: 462\u2013468","journal-title":"J Pharm Exp Ther"},{"key":"22_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/277093a0","volume":"277","author":"JW Kebabian","year":"1979","unstructured":"Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277: 93\u201396","journal-title":"Nature"},{"key":"22_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.2042-7158.1976.tb04143.x","volume":"28","author":"E Mogilnicka","year":"1976","unstructured":"Mogilnicka E, Braestrup C (1976) Noradrenergic influence on the stereotyped behavior induced by amphetamine, phenethylamine and apomorphine. J Pharm Pharmacol 28: 253\u2013255","journal-title":"J Pharm Pharmacol"},{"key":"22_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/BF00427282","volume":"49","author":"L Molander","year":"1976","unstructured":"Molander L, Randrup A (1976) Effects of thymoleptics on behavior associated with changes in brain dopamine. II. Modification and potentiation of apomorphine-induced stimulation of mice. Psychopharmacology 49: 139\u2013144","journal-title":"Psychopharmacology"},{"key":"22_CR25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1600-0773.1973.tb01537.x","volume":"33","author":"I M\u00f8ller Nielsen","year":"1973","unstructured":"M\u00f8ller Nielsen I, Pedersen V, Nymark M, Franck KF, Boeck V, Fjalland B, Christensen AV (1973) The comparative pharmacology of flupenthixol and some reference neuroleptics. Acta Pharmacol Toxicol 33: 353\u2013362","journal-title":"Acta Pharmacol Toxicol"},{"key":"22_CR26","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/BF00427697","volume":"82","author":"AG Molloy","year":"1984","unstructured":"Molloy AG, Waddington JL (1984) Dopaminergic behavior stereospecifically promoted by the Dx agonist SK & F 38393 and selectively blocked by the Dx antagonist SCH 23390. Psychopharmacology 82: 409\u2013410","journal-title":"Psychopharmacology"},{"key":"22_CR27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/BF00421901","volume":"26","author":"M Nymark","year":"1972","unstructured":"Nymark M (1972) Apomorphine provoked stereotypy in the dog. Psychopharmacologia 26: 361\u2013368","journal-title":"Psychopharmacologia"},{"key":"22_CR28","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.1600-0773.1972.tb03612.x","volume":"31","author":"V Pedersen","year":"1972","unstructured":"Pedersen V, Christensen AV (1972) Antagonism of methylphenidate-induced stereotyped gnawing in mice. Acta Pharmacol Toxicol 31: 488\u2013496","journal-title":"Acta Pharmacol Toxicol"},{"key":"22_CR29","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/0024-3205(83)90155-8","volume":"33","author":"H Rosengarten","year":"1983","unstructured":"Rosengarten H, Schweitzer JW, Friedhoff AJ (1983) Induction of oral dyskinesias in naive rats by D-1 stimulation. Life Sci 33: 2479\u20132482","journal-title":"Life Sci"},{"key":"22_CR30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0014-2999(77)90300-4","volume":"42","author":"J Scheel-Kr\u00fcger","year":"1977","unstructured":"Scheel-Kr\u00fcger J, Cools AR, Honig W (1977) Muscimol antagonizes the ergometrine-induced locomotor activity in nucleus accumbens: evidence for GABA-dopaminergic interaction. Eur J Pharmacol 42: 311\u2013313","journal-title":"Eur J Pharmacol"},{"key":"22_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0024-3205(78)90414-9","volume":"22","author":"J Scheel-Kr\u00fcger","year":"1978","unstructured":"Scheel-Kr\u00fcger J, Christensen AV, Arnt J (1978) Muscimol differentially facilitates stereotypy but antagonizes motility induced by dopaminergic drugs: a complex GABA-dopamine interaction. Life Sci 22: 75\u201384","journal-title":"Life Sci"},{"key":"22_CR32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0014-2999(79)90465-5","volume":"53","author":"O Svendsen","year":"1979","unstructured":"Svendsen O (1979) Long term effect of teflutixol on apomorphine-induced stereotypy and vomiting in dogs. Eur J Pharm 53: 387\u2013390","journal-title":"Eur J Pharm"}],"container-title":["Psychopharmacology Supplementum","Dyskinesia"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-70140-5_22.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T08:11:14Z","timestamp":1741853474000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-70140-5_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985]]},"ISBN":["9783642701429","9783642701405"],"references-count":32,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-70140-5_22","relation":{},"ISSN":["0931-6795"],"issn-type":[{"type":"print","value":"0931-6795"}],"subject":[],"published":{"date-parts":[[1985]]}}}